/PRNewswire/ The "Chronic Kidney Disease - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com s offering. This report provides.
The expected launch of therapies by several pharma companies such as ProKidney, Reata Pharmaceuticals, Inc., Novo Nordisk A/S, Boehringer Ingelheim, Eli Lilly and Company, AstraZeneca, and others
/PRNewswire/ DelveInsight s Chronic Kidney Disease Market Insights report includes a comprehensive understanding of current treatment practices, chronic.
/PRNewswire/ DelveInsight s Anorexia Nervosa Market Insights report provides a comprehensive understanding of current treatment practices, Anorexia Nervosa.